Cellectar Biosciences Files Proxy Statement Amendment
Ticker: CLRB · Form: DEFA14A · Filed: Jun 11, 2025 · CIK: 1279704
| Field | Detail |
|---|---|
| Company | Cellectar Biosciences, Inc. (CLRB) |
| Form Type | DEFA14A |
| Filed Date | Jun 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, amendment, shareholder-meeting
TL;DR
Cellectar proxy update filed. Shareholders vote soon.
AI Summary
Cellectar Biosciences, Inc. filed an amendment (Amendment No. 1) to its Definitive Proxy Statement on June 11, 2025. This filing relates to the solicitation of proxies for its upcoming annual meeting of stockholders. The company is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing is crucial for shareholders as it provides updated information and details regarding the company's annual meeting, allowing them to make informed decisions when casting their votes.
Risk Assessment
Risk Level: low — This is a routine proxy filing, providing procedural information rather than significant financial or operational news.
Key Players & Entities
- Cellectar Biosciences, Inc. (company) — Registrant
- 20250611 (date) — Filing Date
- DEFA14A (document_type) — Filing Type
- 100 CAMPUS DRIVE (address) — Business Address
- FLORHAM PARK (location) — City
- NJ (state) — State
- 07932 (zip_code) — Zip Code
- NOVELOS THERAPEUTICS, INC. (company) — Former Company Name
- COMMON HORIZONS INC (company) — Former Company Name
FAQ
What is the purpose of this DEFA14A filing?
This filing is an Amendment No. 1 to the Definitive Proxy Statement, used by Cellectar Biosciences, Inc. to solicit proxies from its stockholders for its annual meeting.
When was this filing submitted to the SEC?
The filing was submitted on June 11, 2025.
What is the company's primary business sector?
Cellectar Biosciences, Inc. is in the Pharmaceutical Preparations sector, with SIC code 2834.
What is the company's state of incorporation?
Cellectar Biosciences, Inc. is incorporated in Delaware (DE).
Has the company operated under previous names?
Yes, the company was formerly known as NOVELOS THERAPEUTICS, INC. and COMMON HORIZONS INC.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on June 11, 2025 regarding Cellectar Biosciences, Inc. (CLRB).